EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Deep Eutectic Solvents as Emerging Green Reaction Media for 1,3-Azole Synthesis: Advances, Challenges, and Future Perspectives

Pavankumar N. Nagtilak, Soyal R. Kumathe, Rutuja S. Kale, Rohini S. Barbole, Maruti V. Jodmote, Vaishnavi D. Deshmukh, Vikas Dadabhau Kadu

Synthesis · 2026-11 · 58 (21) · 2419-2441

DOI: 10.1055/a-2925-0503 ↗
AbstractBibliografische Angaben

Abstract

Abstract Deep eutectic solvents (DESs) have gained significant attention as eco-friendly and sustainable reaction media in various organic transformations. As well, 1,3-azole frameworks exhibit crucial role in medicinal, pharmaceutical, and material science encircling to their diverse application. Traditional synthesis methods of 1,3-azoles typically employed volatile organic solvents and ionic liquids often associated with disadvantages such as toxicity, high cost, and limited recyclability inadequate toward development of sustainable synthetic process. As a consequence, considerable attention has been directed toward the development of efficient, environmentally benign, and sustainable synthetic methodologies. Herein, the recent advances on DES-mediated synthesis of 1,3-azoles are summarized, emphasizing mechanistic insights with various substrate scope as well as DES-substrate and solvent interactions. Specifically, the dual role of DES as solvent and catalyst being the special attention promoting the reaction efficiency through hydrogen-bond activation, proton-transfer, and intermediate stabilization. The advantages and limitations of DES are analyzed, highlighting their future prospects for the development of more efficient, scalable, and sustainable strategies for the 1,3-azole synthesis and diverse DES-based organic transformations.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →